|
When MAGNEVIST® (gadopentetate dimeglumine) injection was introduced in 1988, it ushered in the revolutionary concept of contrast-enhanced magnetic resonance imaging (MRI). It became the world's first contrast agent for use in MRI. Today, the product is still the MR market leader with a broad range of adult and pediatric clinical indications in CNS, head, neck and body (excluding the heart) of any MR contrast agent. MAGNEVIST is used in over 100 countries and has established a positive clinical experience in more than 80 million procedures worldwide. MAGNEVIST is also the most widely studied MR contrast agent with more than 14,000 citations in scientific literature. Clinical indications are also being pursued in vasculature and cardiac imaging.
|
